QuitPuff: A Simple Method using lipid Peroxidative Changes in Saliva to Assess the Risk of Oral Precancerous Lesions and Oral Squamous Cell Carcinoma in Chronic Smokers

Abstract

Introduction: Smoking, the leading cause of oral cancer in India, kills over 5 people every hour. As high mortality is due to late diagnosis, early detection is vital. Free radical-induced lipid peroxidation (LP) is known to promote multistep oral carcinogenesis. Free radicals generated by smoking damage polyunsaturated fatty acids releasing end product malondialdehyde (MDA). A simple, home-based test was devised to determine salivary MDA to assess early risk of oral precancer and cancer. It was hypothesized that heavier smokers would exhibit greater degree of salivary LP. Materials and Methods: A highly sensitive QuitPuff reagent was formulated which when heated with saliva, produces a color change, directly proportional to the amount of MDA. The MDA level was measured by matching the color change with a colorimetric LP index (LPI) chart. QuitPuff was tested on 500 subjects, validated using the gold standard, ultraviolet (UV) spectroscopy. Results: The mean LPI was consistently and significantly elevated (P < 0.001) in smokers with oral precancer and cancer (4.34) and smokers who smoked more than 20 (4.12), between 10 and 20 (3.43), and <10 cigarettes per day (2.43) as compared to nonsmokers (0.26). The mean LPIs of the test and validation methods correlated. Spearman's correlation indicated significant positive association between color changes and UV spectroscopy readings (r = 0.93). QuitPuff detected salivary MDA levels with 96% accuracy. Conclusion: Smokers exhibited greater degree of salivary LP as compared to nonsmokers; the heavier the smoker, greater was the degree of LP. QuitPuff has great potential as a point-of-care test for oral precancer and cancer.

Keywords

Lipid peroxidation - oral cancer detection - oral cancer diagnosis - oral cancer in chronic smokers - salivary diagnostic test for oral cancer

• References

• 1 Bano S, David MP, Indira AP. Salivary biomarkers for oral squamous cell carcinoma: An overview. IJSS Case Rep Rev 2015; 1: 39-45
• 2 Markopoulos AK, Michailidou EZ, Tzimagiorgis G. Salivary markers for oral cancer detection. Open Dent J 2010; 4: 172-8
• 3 Gupta B, Ariyawardana A, Johnson NW. Oral cancer in India continues in epidemic proportions: Evidence base and policy initiatives. Int Dent J 2013; 63: 12-25
• 4 Feller L, Lemmer J. Oral squamous cell carcinoma: Epidemiology, clinical presentation and treatment. J Cancer Ther 2012; 3: 263-8
• 5 Krishna Rao SV, Mejia G, Roberts-Thomson K, Logan R. Epidemiology of oral cancer in Asia in the past decade—an update (2000-2012). Asian Pac J Cancer Prev 2013; 14: 5567-77
• 6 Lin WJ, Jiang RS, Wu SH, Chen FJ, Liu SA. Smoking, alcohol, and betel quid and oral cancer: A prospective cohort study. J Oncol 2011; 2011: 525976
• 7 Mehrotra R, Yadav S. Oral squamous cell carcinoma: Etiology, pathogenesis and prognostic value of genomic alterations. Indian J Cancer 2006; 43: 60-6
• 8 Shah FD, Begum R, Vajaria BN, Patel KR, Patel JB, Shukla SN. et al. A review on salivary genomics and proteomics biomarkers in oral cancer. Indian J Clin Biochem 2011; 26: 326-34
• 9 Shetty SR, Babu S, Kumari S, Shetty P, Hegde S, Castelino R. Status of salivary lipid peroxidation in oral cancer and precancer. Indian J Med Paediatr Oncol 2014; 35: 156-8
• 10 Rai B, Kharb S, Jain R, Anand SC. Salivary lipid peroxidation product malonaldehyde in various dental diseases. World J Med Sci 2006; 1: 100-1
• 11 Ganesan A, Kumar N G. Assessment of lipid peroxides in multiple biofluids of leukoplakia and oral squamous cell carcinoma patients – A clinico- biochemical study. J Clin Diagn Res 2014; 8: ZC55-8
• 12 Arathi A, D'Souza B, Sayanthan M, Raksha S, Buthesh GA, Jisha K. et al. Salivary malondialdehyde and antioxidant status in oral squamous cell carcinoma patients and smokers. Biomed Res 2010; 21: 67-70
• 13 Shivashankara AR, Kavya PM. Salivary total protein, sialic acid, lipid peroxidation and glutathione in oral squamous cell carcinoma. Biomed Res 2011; 22: 355-9
• 14 Kaur J, Politis C, Jacobs R. Salivary 8-hydroxy-2-deoxyguanosine, malondialdehyde, vitamin C, and vitamin E in oral pre-cancer and cancer: Diagnostic value and free radical mechanism of action. Clin Oral Invest 2016; 20: 315-9
• 15 Abdolsamadi H, Rafieian N, Goodarzi MT, Feradmal J, Davoodi P, Jazayeri M. et al. Levels of salivary antioxidant vitamins and lipid peroxidation in patients with oral lichen planus and healthy individuals. Chonnam Med J 2014; 50: 58-62
• 16 Ohkawa H, Ohishi N, Yagi K. Assays for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-8
• 17 Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978; 52: 302-10
• 18 Esterbauer H, Cheeseman KH. Determination of aldehydic lipid peroxidation products: Malonaldehyde and 4-hydroxynonenal. Methods Enzymol 1990; 186: 407-21
• 19 Uchiyama M, Mihara M. Determination of malondialdehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 1978; 86: 271-8
• 20 Asakawa T, Matsushita S. Coloring condition of thiobarbituric acid test for detecting lipid hydroperoxides. Lipids 1980; 15: 137-40
• 21 Mishra S, Joseph RA, Gupta PC, Pezzack B, Ram F, Sinha DN. et al. Trends in bidi and cigarette smoking in India from 1998 to 2015, by age, gender and education. BMJ Glob Health 2016; 1: e000005